Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Galapagos NV (GLPG)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjgren's syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, lupus membranous nephropathy, and uveitis. The company's clinical stage programs also comprise GLPG1690, an autotaxin inhibitor that is in ISABELA I and II trials for idiopathic pulmonary fibrosis (IPF), and NOVESA Phase II proof-of-concept trial for systemic sclerosis; and GLPG1205, a GPR84 inhibitor, which is in the PINTA Phase II proof of concept trial for treating IPF.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: - -
Low: - -
Close: - -

Technical analysis

as of: 2020-08-13 4:34:38 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 221.64 -10000000000    One year: 258.88 -10000000000
Support: Support1: 186.62 -10000000000   Support2: 184.68 -10000000000
Resistance: Resistance1: 189.76 -10000000000   Resistance2: 221.64 -10000000000
Pivot: -10000000000
Moving Average: MA(5):     MA(20):
MA(100):     MA(250):
MACD: MACD(12,26): -10000000000.00 -10000000000    Signal(9): -10000000000.00 -10000000000
Stochastic oscillator: %K(14,3): -10000000000.00 -10000000000    %D(3): -10000000000.00 -10000000000
RSI: RSI(14): -10000000000.00 -10000000000
52-week: High: 189.76  Low: 184.68  Change(%):
Average Vol(K): 3-Month: -10000000000  10-Days: -10000000000

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GLPG has closed Bollinger Bands are 0% narrower than normal.

Headline News

Thu, 13 Aug 2020
Form 6-K GALAPAGOS NV For: Aug 12 - StreetInsider.com

Wed, 12 Aug 2020
Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease - GlobeNewswire

Mon, 10 Aug 2020
RBC Capital Stick to Their Hold Rating for Galapagos NV - Investing.com

Sat, 08 Aug 2020
Galapagos NV (GLPG) Q2 2020 Earnings Call Transcript - The Motley Fool

Fri, 07 Aug 2020
Edited Transcript of GLPG.AS earnings conference call or presentation 7-Aug-20 12:00pm GMT - Yahoo Finance

Fri, 07 Aug 2020
Galapagos NV's (GLPG) CEO Onno van de Stolpe on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.